Australian Business Growth Fund makes first investment

Battery and electric vehicle technology company 3ME technology has been revealed as the first investment of the Australian Business Growth Fund, a joint partnership between the federal government and Australia’s major financial institutions. Based in the Hunter region, 3ME Technology will receive $15 million from the fund, which was established in 2020 and provided an…

Details

Going Dutch – Fortescue planning Australian solar PV factory

Andrew Forrest’s Fortescue Future Industries has purchased a Dutch green hydrogen and solar PV business and announced a major expansion including plans to build a solar PV manufacturing plant in Australia. FFI has purchased a 60 per cent stake in Dutch-based High yield Energy Technologies (HyET) Group and provided the majority share of financing for…

Details

Boxer introduced with live fire exercises

The army has successfully completed two Boxer turret conversion courses in Queensland as it begins introducing the Boxer Combat Reconnaissance Vehicle to service. Live fire exercises at the Townsville Field Training Area, Queensland have qualified 35 armoured cavalry crew on new digital sensors, next generation thermal sights and mission systems in the Boxer’s turret. The…

Details

Calix low-carbon cement costs lowest of competing technologies

By Peter Roberts A European Union funded consortium has released the final project report that the entire construction sector is waiting for – official confirmation that the technology developed by Australian company Calix offers the cheapest way yet discovered to de-carbonise the cement industry. Cement, along with steel, are seen as the most vital yet…

Details

BioCina takes over Pfizer site, will add mRNA vaccine capabilities

Adelaide pharmaceutical group BioCina has announced the final transfer to it of ownership of the microbial-based pharmaceutical manufacturing facility formally operated by Hospira Adelaide, an affiliate of Pfizer Inc. The former-Pfizer site in Adelaide will now be operated by the company as a contract development and biologics manufacturing organization (CDMO) specialising in process development and…

Details